Company Profile
ATAI Life Sciences Stock Price, News & Analysis
- Ticker:
- ATAI
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- Germany with U
Stock performance
7.18 USD (-0.55%)
Close
Last updated: August 6, 2026
1.77B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ATAI closed down 0.55% at $7.18. No new same-company headline was identified in the current news window.
Company overview
Business overview
atai Life Sciences is a mental-health company building a portfolio around psychedelic and novel neuropsychiatric therapies. Its story is centered on the possibility of new treatment paradigms for depression and related disorders.
Geographic Base and Sector Classification
Headquartered in Germany with U.S. market exposure and listed on NASDAQ as an ADR, atai has a global mental-health biotech profile.
Business Model Characteristics
The company depends on clinical data, regulatory progress, and the commercial viability of novel psychiatric treatments.
Position Within the Biotechnology Landscape
atai is a high-catalyst CNS name with strong sensitivity to clinical and regulatory outcomes.
Future catalysts
ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter. The stock will move if the clinical path keeps looking more practical and less experimental.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ATAI Life Sciences (ATAI)?
ATAI Life Sciences (ATAI) most recently closed at 7.18 USD, a -0.55% move versus the previous session.
What is the market cap of ATAI Life Sciences (ATAI)?
ATAI Life Sciences currently has a market capitalization of 1.77B USD on BioPharmSignal.
What does ATAI Life Sciences do?
atai Life Sciences is a mental-health company building a portfolio around psychedelic and novel neuropsychiatric therapies. Its story is centered on the possibility of new treatment paradigms for depression and related disorders.
On which exchange is ATAI stock listed?
ATAI Life Sciences (ATAI) is associated with NASDAQ, Germany with U, Life Science Tools.
What is BPL-003?
ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter.
Which conditions is ATAI Life Sciences targeting with BPL-003?
ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter.
How does ATAI Life Sciences describe recent progress with BPL-003?
ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter.
What is VLS-01?
ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter.